then leveraged his lab's expertise in genomics and bioinformatics to generate the gene expression data and computationally identify the genes associated with osteoarthritis risk. Brian Diekman ...

Osteoarthritis (OA), the most common joint ... their activities might be further enhanced via targeted gene therapy Delivery of MSCs might be achieved either by direct intra-articular injection ...

Ampio Pharma's candidate therapy for knee osteoarthritis has been knocked back by the FDA, which will likely now require a new clinical trial of the drug before it will consider a review.

Allegro NV, a biomedical company developing transformative nanotechnology-based treatments for degenerative joint disease, has found that hydrocelin (ALG-001), its injectable microparticle hydrogel, ...